- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.01. | CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus | 2 | Zacks | ||
| CAPSOVISION Aktie jetzt für 0€ handeln | |||||
| 29.12.25 | CapsoVision beantragt FDA-Zulassung für KI-gestützte Kapselendoskopie | 7 | Investing.com Deutsch | ||
| 29.12.25 | CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus | 1 | GlobeNewswire (USA) | ||
| 29.12.25 | CapsoVision, Inc - 8-K, Current Report | - | SEC Filings | ||
| 05.12.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 05.12.2025 | 725 | Xetra Newsboard | The following instruments on XETRA do have their first trading 05.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 05.12.2025
Aktien
1 US1409351079 CapsoVision Inc.
2... ► Artikel lesen | |
| 14.11.25 | Benchmark reiterates Speculative Buy rating on CapsoVision stock at $5 | 1 | Investing.com | ||
| 14.11.25 | CapsoVision Q3 Loss Widens As Operating Costs Increase | 3 | RTTNews | ||
| 13.11.25 | CapsoVision, Inc. GAAP EPS of -$0.17 misses by $0.04, revenue of $3.54M misses by $0.14M | 6 | Seeking Alpha | ||
| 13.11.25 | CapsoVision, Inc - 10-Q, Quarterly Report | - | SEC Filings | ||
| 10.11.25 | CapsoVision beantragt FDA-Sonderstatus für Diagnosekapsel zur Bauchspeicheldrüsenkrebs-Früherkennung | 2 | Investing.com Deutsch | ||
| 10.11.25 | CapsoVision seeks FDA breakthrough status for pancreatic cancer tool | 1 | Investing.com | ||
| 10.11.25 | CapsoVision, Inc - 8-K, Current Report | - | SEC Filings | ||
| 03.11.25 | CapsoVision, Inc - 8-K, Current Report | - | SEC Filings | ||
| 30.10.25 | CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025 | 3 | GlobeNewswire (USA) | ||
| 26.09.25 | CapsoVision, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 03.07.25 | CapsoVision Announces Closing of Initial Public Offering | 256 | GlobeNewswire (Europe) | SARATOGA, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence ("AI")... ► Artikel lesen | |
| 03.07.25 | Pre-market Movers: Global Interactive Technologies, MDB Capital, Empro Group, CapsoVision, Windtree Therapeutics | 1.429 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.55 A.M. ET).In the Green Global Interactive Technologies, Inc. (GITS) is up... ► Artikel lesen | |
| 02.07.25 | CapsoVision Prices IPO Of 5.50 Mln Shares At $5.00/shr | 858 | AFX News | WASHINGTON (dpa-AFX) - CapsoVision Inc. (CV), a commercial-stage medical technology company that develops
advanced imaging and artificial intelligence technologies that are deployed in its... ► Artikel lesen | |
| 02.07.25 | CapsoVision Announces Pricing of Initial Public Offering | 184 | GlobeNewswire (Europe) | SARATOGA, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence ("AI")... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 18,860 | -1,77 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| PROGYNY | 17,800 | +1,60 % | INVO Fertility, Inc.: INVO Fertility's Wisconsin Clinic Joins Progyny Network | ||
| PROCEPT BIOROBOTICS | 26,600 | +2,62 % | Truist cuts Procept BioRobotics stock price target on lower forecasts | ||
| LIFESTANCE HEALTH GROUP | 7,325 | +2,45 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 23,910 | +2,44 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| INNOVAGE | 10,610 | +14,46 % | InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025 | DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen | |
| NEUROPACE | 13,960 | -1,34 % | Why NeuroPace Stock Was Inching Higher on Wednesday | ||
| PRIVIA HEALTH GROUP | 24,310 | +1,21 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| BETA BIONICS | 11,380 | -6,80 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| TALKSPACE | 4,930 | +1,75 % | Talkspace Announces Fourth Quarter and Full Year 2025 Results | 4Q 2025 total revenue grew 29% year-over-year to $63.0 million4Q 2025 net income of $4.8 million and adjusted EBITDA1 of $6.6 million Full-year 2025 total revenue grew 22% year-over-year to $228.9... ► Artikel lesen | |
| ADAPTHEALTH | 9,670 | +0,36 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| AVEANNA HEALTHCARE | 7,410 | -0,27 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| LUMEXA IMAGING | 15,520 | -2,14 % | Lumexa Imaging Holdings, Inc. - 8-K, Current Report | ||
| CONCENTRA GROUP | 23,560 | -0,72 % | Concentra outlines $2.25B-$2.35B 2026 revenue target while expanding de novo and M&A strategy | ||
| ESSILORLUXOTTICA | 216,80 | -2,43 % | BARCLAYS stuft EssilorLuxottica auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für EssilorLuxottica mit einem Kursziel von 355 Euro auf "Overweight" belassen. Nutzzahlen zeigten, dass Smartglasses... ► Artikel lesen |
Das Unternehmen CAPSOVISION INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 4,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAPSOVISION INC finden Sie auf Wallstreet Online.